DIVIS GREGORY J (Chief Executive Officer) received a stock award from AVADEL PHARMACEUTICALS PLC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/7/2025ACC: 0001104659-25-021732
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+362K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
362K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+52K
Price / share
—
Trade value
—
% of position
32.7%
3/5/2025
159.10K→211.10K
Total
Net shares
+52K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/5/2025 | A · Award | +52K | — | — | 32.7% | 159.10K | 211.10K |
| Total | +52K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
310K shares
Shares
+310K
Strike price
7.87
Held after
310K
Exercisable
—
3/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares310K shares | 3/5/2025 | A · Award | +310K | 7.87 | — | 310K |
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned10K
Total
10K indirect10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 10K | Indirect |
| Total | 10K | 10K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported